⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27984196 | 0.76 | GABRA5 (0.37) | — | |
| SCHEMBL27782412 | 0.73 | — | — | |
| SCHEMBL19223362 | 0.73 | CYP11B1 (0.38) | — | |
| SCHEMBL15153529 | 0.71 | SLC1A3 (0.53) | — | |
| SCHEMBL860093 | 0.69 | CYP11B2 (0.36) | — | |
| SCHEMBL22236496 | 0.69 | CYP11B1 (0.36) | — | |
| SCHEMBL5391398 | 0.67 | CYP11B1 (0.45) | — | |
| SCHEMBL6950271 | 0.66 | CYP11B1 (0.44) | — | |
| SCHEMBL3954746 | 0.66 | CYP3A4 (0.35) | — | |
| SCHEMBL5657526 | 0.63 | CYP11B1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137822-A1 | MULTIVALENT IMMUNOCONJUGATES FOR TARGETED RADIOISOTOPE THERAPY | ABDERA THERAPEUTICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4577250-A1 | MULTIVALENT IMMUNOCONJUGATES FOR TARGETED RADIOISOTOPE THERAPY | Abdera Therapeutics Inc. (US) | 2025-07-02 | — | — | EP | disclosed |
| WO-2024044551-A1 | MULTIVALENT IMMUNOCONJUGATES FOR TARGETED RADIOISOTOPE THERAPY | Abdera Therapeutics Inc. (US) | 2024-02-29 | — | — | WO | disclosed |
| EP-4288109-A1 | IMMUNOSTIMULATORY COMPOUNDS AND CONJUGATES | Seagen Inc. (US) | 2023-12-13 | — | — | EP | disclosed |
| CN-110249050-A | Without label coding library of compounds | 南纳治疗有限公司 | 2019-09-17 | — | — | CN | disclosed |
| CN-110049780-A | Isoquinolinebenzodiazepine (IQB) -1 (chloromethyl) -2, 3-dihydro-1H-benzo [ E ] indole (CBI) dimer | 塞勒兰特治疗公司 | 2019-07-23 | — | — | CN | disclosed |
| CN-109963870-A | ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 艾伯维公司 | 2019-07-02 | — | — | CN | disclosed |
| CN-109641962-A | anti-B7-H3 antibodies and antibody drug conjugates | 艾伯维公司 | 2019-04-16 | — | — | CN | disclosed |
| CN-109563167-A | ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 艾伯维公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-106459200-A | Anti-EGFR antibodies and antibody drug conjugates | 艾伯维公司 | 2017-02-22 | — | — | CN | disclosed |
| WO-2007062138-A2 | METHODS AND COMPOSITIONS FOR TREATING DISEASES TARGETING HUMAN PROMININ-1(CD133) | APPLERA CORPORATION (US) | 2007-05-31 | — | — | WO | disclosed |